Citation Impact
Citing Papers
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
2007 Standout
Gene conversion in steroid 21-hydroxylase genes.
1990
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Mapping and Quantification of Over 2000 O-linked Glycopeptides in Activated Human T Cells with Isotope-Targeted Glycoproteomics (Isotag)
2018 StandoutNobel
Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases
2020 StandoutNobel
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
2018
Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis
2000
Formaldehyde in China: Production, consumption, exposure levels, and health effects
2009
Clinical and Molecular Genetics of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
1991
Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?
2000
Combined Immunodeficiencies with Nonfunctional T Lymphocytes
2014
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
Thymus, innate immunity and autoimmune arthritis: Interplay of gene and environment
2011 StandoutNobel
Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis
2004
Gene Conversions and Rearrangements Cause Discordance Between Inheritance of Forms of 21-Hydroxylase Deficiency and HLA Types*
1989
Physiology and immunology of the cholinergic antiinflammatory pathway
2007 Standout
Complement: coming full circle
2009
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Deletion Hybrid Genes, due to Unequal Crossing Over betweenCYP11B1(11β-Hydroxylase) andCYP11B2(Aldosterone Synthase) Cause Steroid 11β-Hydroxylase Deficiency and Congenital Adrenal Hyperplasia1
2001
Coordinated regulation of myeloid cells by tumours
2012 Standout
Risk factors for thrombophilia in extrahepatic portal vein obstruction†
2005
Complement in human diseases: Lessons from complement deficiencies
2009
Bioequivalence and the immunogenicity of biopharmaceuticals
2002
Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
2004
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Nonresolving Inflammation
2010 Standout
Vascular disorders of the liver # †
2008 Standout
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
2001 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Neutrophils and immunity: challenges and opportunities
2006 Standout
Emerging roles for protein S-palmitoylation in immunity from chemical proteomics
2013
RAG-dependent primary immunodeficiencies
2006
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
2007
Reflex control of immunity
2009 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Tenascin–X deficiency is associated with Ehlers–Danlos syndrome
1997
Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
2000
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Systemic Lupus Erythematosus
2011 Standout
Matrix metalloproteinases as modulators of inflammation and innate immunity
2004 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Resolution of inflammation: the beginning programs the end
2005 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
The Role of Bacterial Polysaccharide Capsules as Virulence Factors
1990
Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively.
1991
PROTAC targeted protein degraders: the past is prologue
2022 Standout
A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection
2005
Complement
2001 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity
2009
Mutations in Steroid 21-Hydroxylase (CYP21)
1994
Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4
2001
Physiology and Pathophysiology of Complement: Progress and Trends
1995
Molecular Genetics of 21- Hydroxylase Deficiency
2010
Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study
2004
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Points of control in inflammation
2002 StandoutNature
Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
1992
A Novel Mutation L260P of the Steroidogenic Acute Regulatory Protein Gene in Three Unrelated Patients of Swiss Ancestry with Congenital Lipoid Adrenal Hyperplasia
2005
Indoor residential chemical emissions as risk factors for respiratory and allergic effects in children: a review
2007
Mechanisms of occupational asthma
2009
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Inherited Prothrombotic Defects in Budd-Chiari Syndrome and Portal Vein Thrombosis : A Study From North India
2004
Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus.
1992
Distúrbios trombofílicos em crianças e adolescentes com trombose da veia porta
2003
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Mechanism and Consequences of the Duplication of the Human C4/P450c21/Gene X Locus
1992
Influence of different genotypes on 17‐hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21‐hydroxylase deficiency
2000
Regulatory T Cells and Human Disease
2020 StandoutNobel
Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses
2011 StandoutNobel
21-hydroxylase deficiency families with HLA identical affected and unaffected sibs.
1989
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
2005 Standout
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 1 Diabetes
2004
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency*
2000
Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation.
1994
Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency.
1991
THE ROLE OF COMPLEMENT AND COMPLEMENT RECEPTORS IN INDUCTION AND REGULATION OF IMMUNITY
1998
Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyl oxidase II deficiency.
1995
Inherited Prothrombotic Defects in Budd-Chiari Syndrome and Portal Vein Thrombosis
2004
Isolated Aldosterone Synthase Deficiency Caused by Simultaneous E198D and V386A Mutations in the CYP11B2 Gene1
1998
H deficiency in two brothers with atypical dense intramembranous deposit disease
1986
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
2011
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Phenotype-Genotype Correlation in 56 Women with Nonclassical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
2001
MECHANISMS OF PHAGOCYTOSIS IN MACROPHAGES
1999 Standout
Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.
2000
Formaldehyde in the Indoor Environment
2010 Standout
Development of French Indoor Air Quality Guidelines
2009
The multiple causes of human SCID
2004
Expression of Human 21-Hydroxylase (P450c21) in Bacterial and Mammalian Cells: A System to Characterize Normal and Mutant Enzymes
1990
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
2003 Standout
Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus.
1989
Graded Attenuation of TCR Signaling Elicits Distinct Autoimmune Diseases by Altering Thymic T Cell Selection and Regulatory T Cell Function
2010 StandoutNobel
Immunosurveillance of Alglucerase Enzyme Therapy for Gaucher Patients: Induction of Humoral Tolerance in Seroconverted Patients After Repeat Administration
1999
Prostaglandins and Inflammation
2011 Standout
THE MOLECULAR GENETICS OF 21-HYDROXYLASE DEFICIENCY
1989
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Review: Genetics of systemic lupus erythematosus
1995
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Identification of two glycosylated components of Mycoplasma penetrans: a surface-exposed capsular polysaccharide and a glycolipid fraction
1998 StandoutNobel
GENETICS OF SYSTEMIC LUPUS ERYTHEMATOSUS
1992
Works of B. Uring‐Lambert being referenced
COMPLEMENT COMPONENT C4 DEFICIENCIES AND GENE ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
1993
Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices
1995
The study of a French family with two duplicated C4A haplotypes
1987
Molecular basis of complete C4 deficiency
1989
Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia.
1989
Clinical Manifestations in Humans of Combined C7 and C4 Deficiency Associated with Low Levels of C2, C8, and C9
1991
C2 Reference Typing Report
1990
Lupus Erythematosus Associated With Genetically Determined Deficiency of the Second Component of the Complement
2000
Frequent factor II G20210A mutation in idiopathic portal vein thrombosis
1999
Inhaled formaldehyde exposure: effect on bronchial response to mite allergen in sensitized asthma patients
2006
Complement C4 Phenotypes in Patients with End-Stage Renal Disease
1996
Polymorphism of MHC class III genes: definition of restriction fragment linkage groups and evidence for frequent deletions and duplications
1988
An estimate on the frequency of duplicated haplotypes and silent alleles of human C4 protein polymorphism. I. Investigations in healthy Caucasoid families
1989
Severe combined immunodeficiency caused by deficiency in either the δ or the ε subunit of CD3
2004
Antigenic determinants expressed by human C4 allotypes; a study of 325 families provides evidence for the structural antigenic model
1988
Detection of the Genetic Polymorphism of Human C2 (Native Protein and C2a Fragment) by Immunoblotting after Polyacrylamide Gel Isoelectric Focusing
1985
Familial properdin deficiency associated with chronic discoid lupus erythematosus.
1989
Severe combined immunodeficiency caused by deficiency in either the δ or the ε subunit of CD3
2004
Component Deficiencies: 2. The Fourth Component
1987